TXMD icon

TherapeuticsMD
TXMD

Overview Fund Trends Analyst Outlook Journalist POV

41 hedge funds and large institutions have $11.7M invested in TherapeuticsMD in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

40% less capital invested

Capital invested by funds: $19.4M → $11.7M (-$7.75M)

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$517K
Puts
$296K
Net Calls
Net Calls Change

Top Buyers

1
+$695K
2
+$467K
3
+$144K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$55.6K
5
Charles Schwab
Charles Schwab
California
+$30.2K

Top Sellers

1
-$2.12M
2
-$463K
3
-$224K
4
Millennium Management
Millennium Management
New York
-$111K
5
Group One Trading
Group One Trading
Illinois
-$58.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.53K
27
$1.19K
28
$923
29
$525
30
$450
31
$356
32
$150
33
$77
34
$60
35
$60
36
$41
37
$30
38
$8
39
$4
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2